Mexico Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026
Mexico Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026
SUMMARY
Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Mexican pharmaceuticals market had total revenues of $23.4 billion in 2021, representing a compound annual growth rate (CAGR) of 7.4% between 2016 and 2021.
- The National Institute of Statistics and Geography (INEGI) reported that from 2020 to 2021, the pharmaceuticals market’s GDP increased by 8.4%, reaching a higher level than before the COVID-19 pandemic.
- Demographic factors such as an aging population, poor diets, and sedentary job roles are stimulating demand for pharmaceutical products.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Mexico
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Mexico pharmaceuticals market by value in 2021?
- What will be the size of the Mexico pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Mexico’s pharmaceuticals market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. How does government regulation affect leading players?
8 COMPANY PROFILES
8.1. Bayer AG
8.2. Pfizer Inc.
8.3. Merck & Co., Inc.
8.4. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. How does government regulation affect leading players?
8 COMPANY PROFILES
8.1. Bayer AG
8.2. Pfizer Inc.
8.3. Merck & Co., Inc.
8.4. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Mexico pharmaceuticals market value: $ billion, 2016-21
Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Mexico pharmaceuticals market value forecast: $ billion, 2021-26
Table 4: Mexico pharmaceuticals market share: % share, by value, 2021
Table 5: Bayer AG: key facts
Table 6: Bayer AG: Annual Financial Ratios
Table 7: Bayer AG: Key Employees
Table 8: Bayer AG: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Merck & Co., Inc.: key facts
Table 14: Merck & Co., Inc.: Annual Financial Ratios
Table 15: Merck & Co., Inc.: Key Employees
Table 16: Merck & Co., Inc.: Key Employees Continued
Table 17: Novartis AG: key facts
Table 18: Novartis AG: Annual Financial Ratios
Table 19: Novartis AG: Key Employees
Table 20: Novartis AG: Key Employees Continued
Table 21: Mexico size of population (million), 2017-21
Table 22: Mexico gdp (constant 2005 prices, $ billion), 2017-21
Table 23: Mexico gdp (current prices, $ billion), 2017-21
Table 24: Mexico inflation, 2017-21
Table 25: Mexico consumer price index (absolute), 2017-21
Table 26: Mexico exchange rate, 2017-21
Table 1: Mexico pharmaceuticals market value: $ billion, 2016-21
Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Mexico pharmaceuticals market value forecast: $ billion, 2021-26
Table 4: Mexico pharmaceuticals market share: % share, by value, 2021
Table 5: Bayer AG: key facts
Table 6: Bayer AG: Annual Financial Ratios
Table 7: Bayer AG: Key Employees
Table 8: Bayer AG: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Merck & Co., Inc.: key facts
Table 14: Merck & Co., Inc.: Annual Financial Ratios
Table 15: Merck & Co., Inc.: Key Employees
Table 16: Merck & Co., Inc.: Key Employees Continued
Table 17: Novartis AG: key facts
Table 18: Novartis AG: Annual Financial Ratios
Table 19: Novartis AG: Key Employees
Table 20: Novartis AG: Key Employees Continued
Table 21: Mexico size of population (million), 2017-21
Table 22: Mexico gdp (constant 2005 prices, $ billion), 2017-21
Table 23: Mexico gdp (current prices, $ billion), 2017-21
Table 24: Mexico inflation, 2017-21
Table 25: Mexico consumer price index (absolute), 2017-21
Table 26: Mexico exchange rate, 2017-21
LIST OF FIGURES
Figure 1: Mexico pharmaceuticals market value: $ billion, 2016-21
Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Mexico pharmaceuticals market value forecast: $ billion, 2021-26
Figure 4: Forces driving competition in the pharmaceuticals market in Mexico, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Mexico, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Mexico, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2021
Figure 10: Mexico pharmaceuticals market share: % share, by value, 2021
Figure 1: Mexico pharmaceuticals market value: $ billion, 2016-21
Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Mexico pharmaceuticals market value forecast: $ billion, 2021-26
Figure 4: Forces driving competition in the pharmaceuticals market in Mexico, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Mexico, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Mexico, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2021
Figure 10: Mexico pharmaceuticals market share: % share, by value, 2021
